OpenAIRE is about to release its new face with lots of new content and services.
During September, you may notice downtime in services, while some functionalities (e.g. user registration, login, validation, claiming) will be temporarily disabled.
We apologize for the inconvenience, please stay tuned!
For further information please contact helpdesk[at]

fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Backer, Vibeke; Sverrild, Asger; Ulrik, Charlotte Suppli; Bødtger, Uffe; Seersholm, Niels; Porsbjerg, Celeste (2015)
Publisher: Co-Action Publishing
Languages: English
Types: Article
Subjects: airway hyperresponsiveness, spirometry, Original Research Article, reversibility, specificity, Asthma management, sensitivity, diagnostic tools, Asthma management; diagnostic tools; airway hyperresponsiveness; spirometry; reversibility; sensitivity; specificity

Classified by OpenAIRE into

mesheuropmc: respiratory tract diseases
Objective: The best strategy for diagnosing asthma remains unclear. Accordingly, the aim of this study was to evaluate diagnostic strategies in individuals with possible asthma referred to a respiratory outpatient clinic at a university hospital.Methods: All individuals with symptoms suggestive of asthma referred over 12 months underwent spirometry, bronchodilator reversibility test, Peak expiratory flow rate (PEF) registration, and bronchial challenge test with methacholine and mannitol on three separate days. The results of these tests were compared against an asthma diagnosis based on symptoms, presence of atopy and baseline spirometry made by a panel of three independent respiratory specialists.Results: Of the 190 individuals examined, 63% (n=122) were classified as having asthma. Reversibility to β2-agonist had the lowest sensitivity of 13%, whereas airway hyperresponsiveness to methacholine had the highest (69%). In contrast, specificity was the highest for reversibility testing (93%), whereas methacholine had the lowest specificity (57%). The combination of reversibility, peak-flow variability, and methacholine yielded a cumulative sensitivity of 78%, albeit a specificity of 41%. In comparison, a combination of reversibility and mannitol resulted in a specificity of 82% and a sensitivity of 42%.Conclusion: In this real-life population, different diagnostic test combinations were required to achieve a high specificity for diagnosing asthma and a high sensitivity, respectively: Our findings suggest that the diagnostic test approach should be based on whether the aim is to exclude asthma (high sensitivity required) or confirm a diagnosis of asthma (high specificity required).Keywords: Asthma management; diagnostic tools; airway hyperresponsiveness; spirometry; reversibility; sensitivity; specificity(Published: 7 July 2015)Citation: European Clinical Respiratory Journal 2015, 2: 27768 -
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Thomsen SF, Ulrik CS, Kyvik KO, Larsen K, Skadhauge LR, Steffensen I, et al. The incidence of asthma in young adults. Chest. 2005; 127: 1928 34.
    • 2. To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Pub Health. 2012; 12: 204.
    • 3. Nolte H, Nepper-Christensen S, Backer V. Unawareness and undertreatment of asthma and allergic rhinitis in a general population. Respir Med. 2006; 100: 354 62.
    • 4. Lund TK, Pedersen L, Anderson SD, Sverrild A, Backer V. Are asthma-like symptoms in elite athletes associated with classical features of asthma? Br J Sports Med. 2009; 43: 1131 5.
    • 5. Cockcroft DW, Davis BE. Diagnostic and therapeutic value of airway challenges in asthma. Curr Allergy Asthma Rep. 2009; 9: 247 53.
    • 6. Backer V, Harmsen L, Lund T, Pedersen L, Porsbjerg C, Rasmussen L, et al. A 3-year longitudinal study of asthma quality of life in undiagnosed and diagnosed asthma patients. Int J TubercLung Dis. 2007; 11: 463 9.
    • 7. Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008; 63: 1046 51.
    • 8. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An official American Thoracic Society/ European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009; 180: 59 99.
    • 9. Boulet L-P, FitzGerald JM, Levy ML, Cruz AA, Pedersen S, Haahtela T, et al. A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care. Eur Respir J. 2012; 39: 1220 9.
    • 10. Juniper EF, Bousquet J, Abetz L, Bateman ED. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med. 2006; 100: 616 21.
    • 11. Juniper EF, Price DB, Stampone PA, Creemers JP, Mol SJ, Fireman P. Clinically important improvements in asthmaspecific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropion. Chest. 2002; 121: 1824 32.
    • 12. Dreborg S, Belin L, Eriksson NE, Grimmer O, Kunkel G, Malling HJ, et al. Results of biological standardization with standardized allergen preparations. Allergy. 1987; 42: 109 16.
    • 13. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000; 161: 309 29.
    • 14. Porsbjerg C, Brannan JD, Anderson SD, Backer V. Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients. Clin Exp Allergy. 2008; 38: 43 50.
    • 15. Johns DP, Abramson M, Bowes G. Evaluation of a new ambulatory spirometer for measuring forced expiratory volume in one second and peak expiratory flow rate. Am Rev Respir Dis. 1993; 147: 1245 50.
    • 16. Reddy AP, Gupta MR. Management of asthma: the Current US and European Guidelines. Adv Exp Med Biol. 2014; 795: 81 103.
    • 17. Gottlieb V, Lyngso AM, Nybo B, Frolich A, Backer V. Pulmonary rehabilitation for moderate COPD (GOLD 2)--does it have an effect? COPD. 2011; 8: 380 6.
    • 18. Nielsen EW, Hull JH, Backer V. High prevalence of exerciseinduced laryngeal obstruction in athletes. Med Sci Sports Exerc. 2013; 45: 2030 5.
    • 19. Morris MJ, Christopher KL. Diagnostic criteria for the classification of vocal cord dysfunction. Chest. 2010; 138: 1213 23.
    • 20. Ringsberg KC, Wetterqvist H, Lowhagen O, Sivik T. Physical capacity and dyspnea in patients with asthma-like symptoms but negative asthma tests. Allergy. 1997; 52: 532 40.
    • 21. Boulet L-P, O'Byrne PM. Asthma and exercise-induced bronchoconstriction in athletes. N Engl J Med. 2015; 372: 641 8.
    • 22. Sheel AW, Foster GE, Romer LM. Exercise and its impact on dyspnea. Curr Opin Pharmacol. 2011; 11: 195 203.
    • 23. Link MS, Estes NA. Athletes and arrhythmias. J Cardiovasc Electrophysiol. 2010; 21: 1184 9.
    • 24. Boulet L-P, Fitz Gerald JM, Reddel HK. The revised 2014 GINA strategy report: opportunities for change. Curr Opin Pulm Med. 2015; 21: 1 7.
    • 25. Porsbjerg C, Lund TK, Pedersen L, Backer V. Inflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO. J Asthma. 2009; 46: 606 12.
    • 26. Sverrild A, Porsbjerg C, Backer V. The use of inhaled mannitol in the diagnosis and management of asthma. Expert Opin Pharmacother. 2012; 13: 115 23.
    • 27. Sverrild A, Porsbjerg C, Thomsen SF, Backer V. Airway hyperresponsiveness to mannitol and methacholine and exhaled nitric oxide: a random-sample population study. J Allergy Clin Immunol. 2010; 126: 952 8.
    • 28. Roche N, Reddel HK, Agusti A, Bateman ED, Krishnan JA, Martin RJ, et al. Integrating real-life studies in the global therapeutic research framework. Lancet Respir Med. 2013; 1: e29 30.
    • 29. Haughney J, Sims E, Holohan J, Ryan D, Price D. Improving clinician-patient communication in asthma: the HARP project. Allergy. 2010; 65: 413 4.
    • 30. Accordini S, Corsico AG, Braggion M, Gerbase MW, Gislason D, Gulsvik A, et al. The cost of persistent asthma in Europe: an international population-based study in adults. Int Arch Allergy Immunol. 2013; 160: 93 101.
    • 31. Hansen CL, Baelum J, Skadhauge L, Thomsen G, Omland O, Thilsing T, et al. Consequences of asthma on job absenteeism and job retention. Scand J Public Health. 2012; 40: 377 84.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok